Synthesis, Antioxidant, Xanthine Oxidase and Urease Inhibitory Activities of Some Chlorine Containing Benzimidazoles

Abstract

Aseries of tetra-substitued benzimidazole derivatives were synthesized and screened for their urease inhibi- tion, anti-xanthine oxidase XO and antioxidant activities. Some of them were found to possess significant antioxidant activity, especially, compounds 4, 5a, 5b, 5c, 5d and 6b exhibited highly scavenging activity in ABTS•+ radical cation decolorization assay SC50: 9.51-70.43 μg/mL and cupric reducing antioxidant capacity CUPRAC assay. Compound 6d exhibited the highest XO inhibition at 125 μg/mL. All compounds were evalua- ted with regard to Jack Bean urease activity and the most active compound concerning urease enzyme inhibi- tion was 5b , with an IC50 value of 7.41±0.13 μg/mL.

Keywords

• urease,Xanthine oxidase,enzyme inhibition,antioxidant activity,benzimidazole

Bazı Klor İçeren Benzimidazollerin Sentezi ve Antioksidan, Ksantin Oksidaz ve Üreaz İnhibitör Aktivitelerinin İncelenmesi

Abstract

B ir seri tetra-substitüe benzimidazol türevi sentezlendi ve üreaz inhibisyon, anti-ksantin oksidaz XO ve antioksidan aktiviteleri incelendi. Bazı bileşiklerin önemli derecede antioksidan aktivite gösterdiği tespit edildi. Özellikle, bileşik 4, 5a, 5b, 5c, 5d ve 6b ABTS•+ radikal katyon temizleme SC: 9.51-70.43 µg/mL ve bakır indirgeyici antioksidan kapasite CUPRAC tayininde yüksek derecede aktivite gösterdiği belirlendi. Bileşik 6d ise, 125 µg/mL derişimde en yüksek anti-ksantin oksidaz XO aktivitesi gösterdi. Bütün bileşikler Jack Bean üreaz aktivite tayin yöntemine göre incelendi ve en aktif üreaz inhibisyonuna sahip bileşiğin 7.41±0.13 µg/mL IC değeriyle 5b olduğu tespit edildi

Keywords

• Üreaz,ksantin oksidaz,enzim inhibisyon,antioksidan aktivite,benzimidazol

References

1. M. Li, W.J. Ding, B. Baruah, D.C. Crans, R.L. Wang, Inhibition of protein tyrosine phosphatase 1B and alkaline phosphatase by bis(maltolato)oxovanadium (IV), J Inorg Biochem, 102 (2008) 1846-1853.
2. P.A. Karplus, M.A. Pearson, R.P. Hausinger, 70 years of crystalline urease: What have we learned?, Accounts Chem Res, 30 (1997) 330-337.
3. H.L.T. Mobley, M.D. Island, R.P. Hausinger, Molecular- biology of microbial ureases, Microbiol Rev, 59 (1995) 451-480.
4. X. Li, H.L.T. Mobley, Vaccines for Proteus mirabilish in urinary tract infection, Int J Antimicrob Ag, 19 (2002) 461-465.
5. Z.P. Xiao, T.W. Ma, W.C. Fu, X.C. Peng, A.H. Zhang, H.L. Zhu, The synthesis, structure and activity evaluation of pyrogallol and catechol derivatives as Helicobacter pylori urease inhibitors, Eur J Med Chem, 45 (2010) 5064-5070.
6. Z. Amtul, Atta-ur-Rahman, R.A. Siddiqui, M.I. Choudhary, Chemistry and mechanism of urease inhibition, Curr Med Chem, 9 (2002) 1323-1348.
7. M. Kot, W. Karcz, W. Zaborska, 5-Hydroxy-1,4- naphthoquinone (juglone) and 2-hydroxy-1,4- naphthoquinone (lawsone) influence on jack bean urease activity: Elucidation of the difference in inhibition activity, Bioorg Chem, 38 (2010) 132-137.
8. O. Bekircan, T. Ozen, N. Gumrukcuoglu, H. Bektas, Synthesis and antioxidant properties of some new 3-(4-chlorophenyl)-5-(pyridin-4-yl)-4H-1,2,4-triazole derivatives, Z Naturforsch B, 63 (2008) 548-554.

9. M. Saleem, M. Rafiq, M. Hanif, N.H. Rama, S.Y. Seo, K.H. Lee, Synthesis, urease and acetylcholine esterase inhibition activities of some 1,4-disubstituted thiosemicarbazides and their 2,5-disubstituted thiadiazoles, B Korean Chem Soc, 33 (2012) 2741-2747.
10. R.J. Nijveldt, E. van Nood, D.E.C. van Hoorn, P.G.
11. S. Basoglu, A. Demirbas, S. Ulker, S. Alpay-Karaoglu, N. Demirbas, Design, synthesis and biological activities of some 7-aminocephalosporanic acid derivatives, Eur J Med Chem, 69 (2013) 622-631.
12. S. Uesato, Y. Hashimoto, M. Nishino, Y. Nagaoka, H. Kuwajima, N-substituted hydroxyureas as urease inhibitors, Chem Pharm Bull, 50 (2002) 1280-1282.
13. W.S. Faraci, B.W.V. Yang, D. Orourke, R.W. Spencer, Inhibition of helicobacter-pylori urease by phenyl phosphorodiamidates-mechanism of action, Bioorgan Med Chem, 3 (1995) 605-610.
14. J.B. Park, L. Imamura, K. Kobashi, Kinetic studies of Helicobacter pylori urease inhibition by a novel proton pump inhibitor, rabeprzole, Biol Pharm Bull, 19 (1996) 182-187.
15. H. Nagata, H. Satoh, T. Iwahi, T. Shimoyama, T. Tamura, Potent inhibitory action of the gastric proton pumb inhibitor lansoprazole against urease activity of Helicobacter pylori:unique action selective for H. pylori cells, Antimicrob Agents Ch, 37 (1993) 769-774.
16. T.C. Kuhler, J. Fryklund, N.A. Bergman, J. Weilitz, A. Lee, H. Larsson, Structure-activity relationship of omeprazole and analogs as helicobacter-pylori urease inhibitors, J Med Chem, 38 (1995) 4906-4916.
17. L.G. Bundy, J.M. Bremner, Effects of substitued p-benzoquinones on urease activity in soils, Soil Biol Biochem, 5 (1973) 847-853.
18. M.J. Todd, R.P. Hausinger, Competitive inhibitors of klebsiella-aerogenes urease-mechanisms of interaction with the nickel active-site, J Biol Chem, 264 (1989) 15835-15842.
19. S.A. Sanders, V. Massey, The Thermodynamics of xanthine oxidoreductase catalysis, Antioxid Redox Sign, 1 (1999) 371-379.
20. A.K. Tausche, K. Richter, A. Grassler, S. Hansel, B. Roch, H.E. Schroder, Severe gouty arthritis refractory to anti-inflammatory drugs: treatment with anti- tumour necrosis factor alpha as a new therapeutic option, Ann Rheum Dis, 63 (2004) 1351-1352.
21. M. Fields, C.G. Lewis, M.D. Lure, Allopurinol, an inhibitor of xanthine oxidase, reduces uric acid levels and modifies the signs associated with copper deficiency in rats fed fructose, Free Radical Bio Med, 20 (1996) 595-600.
22. L.D. Kong, Y. Cai, W.W. Huang, C.H.K. Cheng, R.X. Tan, Inhibition of xanthine oxidase by some Chinese medicinal plants used to treat gout, J Ethnopharmacol, 73 (2000) 199-207.
23. A. Umpierrez, J. Cuesta-Herranz, M.D. Heras, M. Lluch-Bernal, E. Figueredo, J. Sastre, Successful desensitization of a fixed drug eruption caused by allopurinol, J Allergy Clin Immun, 101 (1998) 286-287.
24. C.E. Berry, J.M. Hare, Xanthine oxicloreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications, J Physiol-London, 555 (2004) 589-606.
25. S.L. Wallach, The side effects of allopurinol, Hosp Pract, 33 (1998) 22-22.
26. A.P. Sweeney, S.G. Wyllie, R.A. Shalliker, J.L. Markham, Xanthine oxidase inhibitory activity of selected Australian native plants, J Ethnopharmacol, 75 (2001) 273-277. Boelens, K. van Norren, P.A.M. van Leeuwen, Flavonoids: a review of probable mechanisms of action and potential applications, Am J Clin Nutr, 74 (2001) 418-425.
27. M. Ozyurek, B. Bektasoglu, K. Guclu, R. Apak, Measurement of xanthine oxidase inhibition activity of phenolics and flavonoids with a modified cupric reducing antioxidant capacity (CUPRAC) method, Anal Chim Acta, 636 (2009) 42-50.
28. A. Mobinikhaledi, N. Foroughifar, M. Kalhor, M. Mirabolfathy, Synthesis and antifungal activity of novel 2-benzimidazolylimino-5-arylidene-4- thiazolidinones, J Heterocyclic Chem, 47 (2010) 77- 80.
29. J.J. Li, Heterocyclic Chemistry in Drug design, John Wiley and Sons, Hoboken, 2013.
30. J. Velik, V. Baliharova, J. Fink-Gremmels, S. Bull, J. Lamka, L. Skalova, Benzimidazole drugs and modulation of biotransformation enzymes, Res Vet Sci, 76 (2004) 95-108.
31. P. Kohler, The biochemical basis of anthelmintic action and resistance, Int J Parasitol, 31 (2001) 336- 345.
32. M.M. Ramla, M.A. Omar, A.M.M. El-Khamry, H.I. El-Diwani, Synthesis and antitumor activity of 1-substituted-2-methyl-5-nitrobenzimidazoles, Bioorgan Med Chem, 14 (2006) 7324-7332.
33. R. Wubulikasimu, Y.B. Yang, F. Xue, X.J. Luo, D.P. Shao, Y.H. Li, R.M. Gao, W.D. Ye, Synthesis and biological evaluation of novel benzimidazole derivatives bearing a heterocyclic ring at 4/5 position, B Korean Chem Soc, 34 (2013) 2297-2304.
34. G.R. Jadhav, M.U. Shaikh, R.P. Kale, M.R. Shiradkar, C.H. Gill, SAR study of clubbed [1,2,4]-triazolyl with fluorobenzimidazoles as antimicrobial and antituberculosis agents, Eur J Med Chem, 44 (2009) 2930-2935.
35. A. Husain, M. Rashid, M. Shaharyar, A.A. Siddiqui, R. Mishra, Benzimidazole clubbed with triazolo- thiadiazoles and triazolo-thiadiazines: New anticancer agents, Eur J Med Chem, 62 (2013) 785-798.
36. A. Husain, M. Rashid, R. Mishra, S. Parveen, D.S. Shin, D. Kumar, Benzimidazole bearing oxadiazole and triazolo-thiadiazoles nucleus: Design and synthesis as anticancer agents, Bioorg Med Chem Lett, 22 (2012) 5438-5444.
37. D. Ramsbeck, M. Buchholz, B. Koch, L. Bohme, T. Hoffmann, H.U. Demuth, U. Heiser, Structure-activity relationships of benzimidazole-based glutaminyl cyclase inhibitors featuring a heteroaryl scaffold, J Med Chem, 56 (2013) 6613-6625.
38. V. Kovalishyn, J. Aires-de-Sousa, C. Ventura, R.E. Leitao, F. Martins, QSAR modeling of antitubercular activity of diverse organic compounds, Chemometr Intell Lab, 107 (2011) 69-74.
39. A. Khalafi-Nezhad, M.N.S. Rad, H. Mohabatkar, Z. Asrari, B. Hemmateenejad, Design, synthesis, antibacterial and QSAR studies of benzimidazole and imidazole chloroaryloxyalkyl derivatives, Bioorgan Med Chem, 13 (2005) 1931-1938.
40. Y.L. Gong, S.S. Karakaya, X.Y. Guo, P.R. Zheng, B. Gold, Y. Ma, D. Little, J. Roberts, T. Warder, X.J. Jiang, M. Pingle, C.F. Nathan, G. Liu, Benzimidazole-based compounds kill Mycobacterium tuberculosis, Eur J Med Chem, 75 (2014) 336-353.
41. Y.K. Yoon, M.A. Ali, A.C. Wei, A.N. Shirazi, K. Parang, T.S. Choon, Benzimidazoles as new scaffold of sirtuin inhibitors: Green synthesis, in vitro studies, molecular docking analysis and evaluation of their anti-cancer properties, Eur J Med Chem, 83 (2014) 448-454.
42. E. Mentese, N. Karaali, F. Yilmaz, S. Ulker, B. Kahveci, Microwave-assisted synthesis and biological evaluation of some benzimidazole derivatives containing a 1,2,4-triazol ring, Arch Pharm, 346 (2013) 556-561.
43. C. Kus, G. Ayhan-Kilcigil, S. Ozbey, F.B. Kaynak, M. Kaya, T. Coban, B. Can-Eke, Synthesis and antioxidant properties of novel N-methyl-1,3,4-thiadiazol-2- amine and 4-methyl-2H-1,2,4-triazole-3(4H)-thione derivatives of benzimidazole class, Bioorgan Med Chem, 16 (2008) 4294-4303.
44. E. Mentese, S. Ulker, B. Kahveci, Synthesis and study of alpha-glucosidase inhibitory, antimicrobial and antioxidant activities of some benzimidazole derivatives containing triazole, thiadiazole, oxadiazole, and morpholine rings, Chem Heterocycl Comp, 50 (2015) 1671-1682.
45. R. Apak, S. Gorinstein, V. Bohm, K.M. Schaich, M. Ozyurek, K. Guclu, Methods of measurement and evaluation of natural antioxidant capacity/activity (IUPAC Technical Report), Pure Appl Chem, 85 (2013) 957-998.
46. Z. Can, B. Dincer, H. Sahin, N. Baltas, O. Yildiz, S. Kolayli, Polyphenol oxidase activity and antioxidant properties of Yomra apple (Malus communis L.) from Turkey, J Enzym Inhib Med Ch, 29 (2014) 829-835.
47. W. Brandwilliams, M.E. Cuvelier, C. Berset, Use of a Free-Radical Method to Evaluate Antioxidant Activity, Food Sci Technol-Leb, 28 (1995) 25-30.
48. R. Re, N. Pellegrini, A. Proteggente, A. Pannala, M. Yang, C. Rice-Evans, Antioxidant activity applying an improved ABTS radical cation decolorization assay, Free Radical Bio Med, 26 (1999) 1231-1237.
49. T. Hayashi, K. Sawa, M. Kawasaki, M. Arisawa, M. Shimizu, N. Morita, Inhibition of cows milk xanthine- oxidase by flavonoids, J Nat Prod, 51 (1988) 345-348.
50. M.W. Weatherburn, Phenol-hypochlorite reaction for determination of ammonia, Anal Chem, 39 (1967) 971- 974.
51. E. Mentese, F. Yilmaz, N. Karaali, S. Ulker, B. Kahveci, Rapid synthesis and lipase inhibition activity of some new benzimidazole and perimidine derivatives, Russ J Bioorg Chem+, 40 (2014) 336-342.
52. E. Mentese, F. Yılmaz, F.B. Beris, B. Bekircan, B. Kahveci, Microwave-assisted synthesis of some new benzimidazole derivatives with their antimicrobial activity, Current Microwave Chemistry, 2 (2015) 32- 39.
53. E. Mentese, F. Yılmaz, N. Baltas, B. Bekircan, B. Kahveci, Synthesis and antioxidant activities of some new triheterocyclic compounds containing benzimidazole, thiophene, and 1,2,4-triazole rings, J Enzym Inhib Med Ch, 8 (2014) 1-7.